CM
MD icon

Crestline Management’s Pediatrix Medical MD Stock Holding History

Crestline Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-32,000
Closed -$724K – 77
2019
Q3 		$724K Buy
32,000
+12,000
+60% +$274K 0.12% 71
2019
Q2 		$505K Buy
+20,000
New +$537K 0.07% 71

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Crestline Management's MD Position: Q4 2019 in Review

Crestline Management sold out of Pediatrix Medical (MD) in Q4 2019, closing a stake of 32,000 shares — an estimated $724K sold.

Crestline Management first reported a position in MD in Q2 2019 and held it in 2 quarters. The position peaked at $724K in Q3 2019. 258 funds tracked by Wall St. Rank hold MD as of Q4 2019.

  • Crestline Management reported no remaining Pediatrix Medical position as of Q4 2019 after selling out during the quarter.
  • Crestline Management sold 32,000 Pediatrix Medical shares in Q4 2019, an estimated $724K.
  • Crestline Management first reported a position in Pediatrix Medical in Q2 2019 and held it in 2 quarters.
  • Crestline Management's Pediatrix Medical position peaked at $724K in Q3 2019.
  • 258 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2019.

Based on Crestline Management's 13F filing for Q4 2019, filed 12 Feb 2020.